Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Firebrick Pharma Limited ( (AU:FRE) ) just unveiled an update.
Firebrick Pharma Limited reported a significant increase in revenues from ordinary activities, rising by 1,853.33% to $293,000 for the year ended June 30, 2025, compared to the previous year. Despite this revenue growth, the company experienced a substantial net loss of $2.634 million, an increase of 124% from the prior year, highlighting ongoing financial challenges.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates in the pharmaceutical industry, focusing on the development and commercialization of innovative healthcare products.
Average Trading Volume: 94,704
Technical Sentiment Signal: Buy
For a thorough assessment of FRE stock, go to TipRanks’ Stock Analysis page.